About Lifecore
Lifecore is a company based in Chaska (United States) founded in 1965 was acquired by Landec in April 2010. The company has 406 employees as of May 31, 2024. Lifecore offers products and services including Process Development, Clinical Manufacturing, Analytical Services, and Sodium Hyaluronate. Lifecore operates in a competitive market with competitors including Bloomage Biotechnology, Fidia Farma, Contipro, Qingdao Kangyuan Pharmaceutica and Altergon Italia, among others.
- Headquarter Chaska, United States
- Employees 406 as on 31 May, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Lifecore Biomedical, Inc.
-
Annual Revenue
$128.87 M (USD)0.47as on May 31, 2025
-
Net Profit
-$38.72 M (USD)-422.29as on May 31, 2025
-
EBITDA
-$3.98 M (USD)-590.02as on May 31, 2025
-
Latest Funding Round
$24.3 M (USD), Post-IPO
Oct 04, 2024
-
Investors
Wynnefield Capital
& 1 more
-
Employee Count
406
as on May 31, 2024
-
Acquired by
Landec
(Apr 30, 2010)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Lifecore
Lifecore is a publicly listed company on the NASDAQ with ticker symbol LFCR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Lifecore
Lifecore offers a comprehensive portfolio of products and services, including Process Development, Clinical Manufacturing, Analytical Services, and Sodium Hyaluronate.
Services for scaling drug products from concept to commercial supply.
Production and packaging of injectable medical devices and pharmaceuticals.
On-site labs for sample analysis and stability testing.
Non-animal-sourced hyaluronate for research and commercial applications.
People of Lifecore
Unlock access to complete
Funding Insights of Lifecore
Investors in Lifecore
Lifecore has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Wynnefield Capital and Landec.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manages investment funds for sophisticated financial investors worldwide.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Lifecore
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lifecore
Investment portfolio details for Lifecore
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lifecore
Detailed financials for Lifecore
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lifecore Comparisons
Peer comparison for Lifecore
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lifecore
Lifecore operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bloomage Biotechnology, Fidia Farma, Contipro, Qingdao Kangyuan Pharmaceutica and Altergon Italia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Manufacturer of hyaluronic acid & pharmaceutical products
|
|
| Locked | Locked | Locked |
Proprietary hyaluronic acid treatments and derivatives are developed.
|
|
| Locked | Locked | Locked |
Manufacturer of hyaluronic acid-based products
|
|
| Locked | Locked | Locked |
Operates as a CDMO specializing in hyaluronidase manufacturing.
|
|
| Locked | Locked | Locked |
Develops and manufactures pharmaceutical products and medical devices for clients.
|
Detailed competitors of Lifecore
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lifecore
Complete news archive for Lifecore
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lifecore
Lifecore was founded in 1965 and raised its 1st funding round 53 years after it was founded.
Lifecore is headquartered in Chaska, United States. It is registered at Chaska, Minnesota, United States.
As of May 31, 2024, the latest employee count at Lifecore is 406.
Annual revenue of Lifecore is $128.87M as on May 31, 2025.
Lifecore Biomedical, a wholly owned subsidiary of Landec Corporation (Nasdaq: LNDC), is dedicated to the development of technically advanced hyaluronan-based products that offer long-term compatibility with the human body. Since 1986, more than 50 million patients worldwide have benefited from Lifecores innovations in sodium hyaluronate products. The companys products meet or exceed the highest standards set by the United States Food and Drug Administration, the European Community and other international agencies. The Lifecore facility is ISO 13485 and GMP certified, international symbols of quality system assurance and compliance.
Lifecore's top competitors include Bloomage Biotechnology, Fidia Farma and Contipro.
Lifecore offers Process Development, Clinical Manufacturing, Analytical Services, and Sodium Hyaluronate.
Yes, Lifecore is publicly traded on NASDAQ under the ticker symbol LFCR.
Lifecore has 2 investors. Key investors include Wynnefield Capital, and Landec.
The ticker symbol of Lifecore is LFCR on NASDAQ.